clene said friday that it has priced an underwritten public offering of 50 million shares and two tranches of warrants the combined offering price to the public of each share of stock and accompanying warrant is 80 cents all of the shares of common stock and accompanying warrants are being offered by clene the shares of common stock and the accompanying warrants will be issued separately but can only be purchased together in the offering clene expects to receive total proceeds of 40 million the offering is expected to close on or about wednesday clene intends to use the proceeds from this offering together with its existing cash for expenses primarily related to general corporate purposes including to fund the clinical development of our lead drug candidate cnmau8 and other general corporate purposes clene shares were down 28 to 76 cents in premarket trade